When analysis was limited to 41 cases of non-cardia stomach adenocarcinoma, ORs were 17.1 (95% CI 4.0–72.9) and 10.9 (95% CI 3.2–36.9) among carriers of antibodies to Hp-CSAs and CagA, respectively. This evidence concerns the gene S100A8 and gastric adenocarcinoma.